Tratamento da recidiva de reestenose intra-stent renal por angioplastia com balão farmacológico
Drug-coated balloon used to treat in-stent restenosis of the renal artery
Rodrigo Gibin Jaldin, Marcone Lima Sobreira, Regina Moura, Matheus Bertanha, Rafael Elias Fares Pimenta, Ricardo de Alvarenga Yoshida, Jamil Victor de Oliveira Mariúba, Winston Bonetti Yoshida
Resumo
Nos últimos anos, balões farmacológicos surgiram como promissora alternativa terapêutica em intervenções endovasculares. Com essa tecnologia, transferem-se drogas antiproliferativas à parede arterial, sem a necessidade de implante metálico para liberação. Descreve-se o caso de um paciente com uma segunda recidiva de reestenose intra-stent renal tratada por angioplastia com balão coberto por droga, com boa evolução clínica caracterizada por adequado controle pressórico e redução de classes e dosagem dos anti-hipertensivos. Os resultados obtidos com balões farmacológicos em outros territórios e esta experiência isolada podem contribuir como sugestão para o uso desses dispositivos na reestenose intra-stent renal, com resultados iniciais satisfatórios.
Palavras-chave
Abstract
During recent years, drug-coated balloons (DCBs) have emerged as a promising therapeutic option. DCBs directly transfer antiproliferative drugs to the arterial wall in order to decrease myointimal hyperplasia. We describe a case of de novo renal artery in-stent restenosis (ISR) treated with drug-coated balloon angioplasty with acceptable short-term results, achieving blood pressure control using fewer antihypertensive agents. The experience and results obtained with DCBs in other territories could suggest and justify use of this technology in renal artery ISR.
Keywords
References
1. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353(9149):282-6. http://dx.doi.org/10.1016/S0140-6736(98)04432-8. PMid:9929021.
2. Diop AN, Hoang VV, Cassagnes L, et al. Treatment of atheromatous renal artery in-stent restenosis in 51 patients. Diagn Interv Imaging. 2013;94(1):68-77. http://dx.doi.org/10.1016/j.diii.2012.10.007. PMid:23218478.
3. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216(1):78-85. http://dx.doi.org/10.1148/radiology.216.1.r00jl0778. PMid:10887230.
4. Zeller T, Rastan A, Schwarzwalder U, et al. Treatment of instent restenosis following stent-supported renal artery angioplasty. Catheter Cardiovasc Interv. 2007;70(3):454-9. http://dx.doi.org/10.1002/ccd.21220. PMid:17721946.
5. Zähringer M, Pattynama PMT, Talen A, Sapoval M. Drug-eluting stents in renal artery stenosis. Eur Radiol. 2008;18(4):678-82. http://dx.doi.org/10.1007/s00330-007-0789-5. PMid:17929021.
6. Patel M, Patel S, Patel N, Patel N. Drug Eluting stent for restenosis diseases. Afr J Pharm Pharmacol. 2012;6(6):359-67.
7. Boateng FK, Greco BA. Renal artery stenosis: prevalence of, risk factors for, and management of in-stent stenosis. Am J Kidney Dis. 2013;61(1):147-60. http://dx.doi.org/10.1053/j.ajkd.2012.07.025. PMid:23122491.
8. Stone PA, Campbell JE, Aburahma AF, et al. Ten-year experience with renal artery in-stent stenosis. J Vasc Surg. 2011;53(4):1026-31. http://dx.doi.org/10.1016/j.jvs.2010.10.092. PMid:21215576.
9. Kiernan TJ, Yan BP, Eisenberg JD, et al. Treatment of renal artery in-stent restenosis with sirolimus-eluting stents. Vasc Med. 2010;15(1):3-7. http://dx.doi.org/10.1177/1358863X09106897. PMid:19793778.
10. Gray WA, Granada JF. Drug-coated balloons for the prevention of vascular restenosis. Circulation. 2010;121(24):2672-80. http://dx.doi. org/10.1161/CIRCULATIONAHA.110.936922. PMid:20566965.
11. Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011;58(11):1105-9. http://dx.doi.org/10.1016/j.jacc.2011.05.034. PMid:21884945.
12. Itani HS, Mudawwar WA, Tanios BY, Alam SE, Haddad FF. First use of a Drug-eluting Balloon in the treatment of acute renal artery occlusion and in-stent restenosis. Am J Med Sci. 2013;346(3):244-6. http://dx.doi.org/10.1097/MAJ.0b013e31828b2b7f. PMid:23538936.
13. Chi YW, White CJ, Thornton S, Milani RV. Ultrasound velocity criteria for renal in-stent restenosis. J Vasc Surg. 2009;50(1):119-23. http://dx.doi.org/10.1016/j.jvs.2008.12.066. PMid:19233590.
14. Agroyannis B, Chatziioannou A, Mourikis D, et al. Abdominal aortic aneurysm and renal artery stenosis: renal function and blood pressure before and after endovascular treatment. J Hum Hypertens. 2002;16(5):367-9. http://dx.doi.org/10.1038/sj.jhh.1001367. PMid:12082500.
15. Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006;152(1):59-66. http://dx.doi.org/10.1016/j.ahj.2005.09.011. PMid:16824832.
16. Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal artery stenosis. N Engl J Med. 2009;361(20):1953- 62. http://dx.doi.org/10.1056/NEJMoa0905368. PMid:19907042.
17. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13-22. http://dx.doi.org/10.1056/NEJMoa1310753. PMid:24245566.
18. Balzer KM, Pfeiffer T, Rossbach S, et al. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). J Vasc Surg. 2009;49(3):667-75. http://dx.doi.org/10.1016/j.jvs.2008.10.006. PMid:19135837.
19. Guillaumon AT, Rocha EF, Medeiros CAF. Tratamento endovascular da estenose da artéria renal em rim único. J Vasc Bras. 2008;7(2):99-105. http://dx.doi.org/10.1590/S1677-54492008000200003.
20. Baril DT, Lookstein RA, Jacobs TS, Won J, Marin ML. Durability of renal artery stents in patients with transrenal abdominal aortic enografts. J Vasc Surg. 2007;45(5):915-21. http://dx.doi.org/10.1016/j.jvs.2007.01.022. PMid:17391902.
21. Jahraus CD, St Clair W, Gurley J, Meigooni AS. Endovascular brachytherapy for the treatment of renal artery in-stent restenosis using a beta-emitting source: a report of five patients. South Med J. 2003;96(11):1165-8. PMid:14632372.
22. Patel PM, Eisenberg J, Islam MA, Maree AO, Rosenfield KA. Percutaneous revascularization of persistent renal artery instent restenosis. Vasc Med. 2009;14(3):259-64. http://dx.doi. org/10.1177/1358863X08100386. PMid:19651676.
23. Misra S, Thatipelli MR, Howe PW, et al. Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenosis 4mm in diameter or smaller. J Vasc Interv Radiol. 2008;19(6):833-9. http://dx.doi.org/10.1016/j.jvir.2008.03.017. PMid:18503896.
24. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355(20):2113-24. http://dx.doi.org/10.1056/NEJMoa061254. PMid:17101615.
25. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358(7):689-99. http://dx.doi.org/10.1056/NEJMoa0706356. PMid:18272892.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email